Literature DB >> 34447979

Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure.

Peter E Light1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34447979      PMCID： PMC8455342          DOI： 10.1093/eurheartj/ehab563

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   35.855


× No keyword cloud information.
  16 in total

Review 1.  Late sodium current: A mechanism for angina, heart failure, and arrhythmia.

Authors:  Jonathan C Makielski
Journal:  Trends Cardiovasc Med       Date:  2015-05-22       Impact factor: 6.677

2.  Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.

Authors:  Eri T Kato; Michael G Silverman; Ofri Mosenzon; Thomas A Zelniker; Avivit Cahn; Remo H M Furtado; Julia Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Marc P Bonaca; Christian T Ruff; Akshay S Desai; Shinya Goto; Peter A Johansson; Ingrid Gause-Nilsson; Per Johanson; Anna Maria Langkilde; Itamar Raz; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2019-03-18       Impact factor: 29.690

3.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

Review 4.  Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Jacob A Udell; Julie A Lovshin; David Z I Cherney
Journal:  Circulation       Date:  2017-10-24       Impact factor: 29.690

5.  Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure.

Authors:  Nikole J Byrne; Nobutoshi Matsumura; Zaid H Maayah; Mourad Ferdaoussi; Shingo Takahara; Ahmed M Darwesh; Jody L Levasseur; James Won Suk Jahng; Dyonne Vos; Nirmal Parajuli; Ayman O S El-Kadi; Branko Braam; Martin E Young; Subodh Verma; Peter E Light; Gary Sweeney; John M Seubert; Jason R B Dyck
Journal:  Circ Heart Fail       Date:  2020-01-20       Impact factor: 8.790

6.  Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.

Authors:  Hang-Long Li; Gregory-Y H Lip; Qi Feng; Yue Fei; Yi-Kei Tse; Mei-Zhen Wu; Qing-Wen Ren; Hung-Fat Tse; Bernard-M Y Cheung; Kai-Hang Yiu
Journal:  Cardiovasc Diabetol       Date:  2021-05-07       Impact factor: 9.951

7.  Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Authors:  Mikhail Kosiborod; Matthew A Cavender; Alex Z Fu; John P Wilding; Kamlesh Khunti; Reinhard W Holl; Anna Norhammar; Kåre I Birkeland; Marit Eika Jørgensen; Marcus Thuresson; Niki Arya; Johan Bodegård; Niklas Hammar; Peter Fenici
Journal:  Circulation       Date:  2017-05-18       Impact factor: 29.690

8.  Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.

Authors:  David Fitchett; Silvio E Inzucchi; Christopher P Cannon; Darren K McGuire; Benjamin M Scirica; Odd Erik Johansen; Steven Sambevski; Stefan Kaspers; Egon Pfarr; Jyothis T George; Bernard Zinman
Journal:  Circulation       Date:  2019-03-12       Impact factor: 29.690

9.  Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.

Authors:  James P Curtain; Kieran F Docherty; Pardeep S Jhund; Mark C Petrie; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Olof Bengtsson; Anna Maria Langkilde; Mikaela Sjöstrand; Scott D Solomon; John J V McMurray
Journal:  Eur Heart J       Date:  2021-09-21       Impact factor: 29.983

10.  Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.

Authors:  Milton Packer; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Peter Carson; James Januzzi; Subodh Verma; Hiroyuki Tsutsui; Martina Brueckmann; Waheed Jamal; Karen Kimura; Janet Schnee; Cordula Zeller; Daniel Cotton; Edimar Bocchi; Michael Böhm; Dong-Ju Choi; Vijay Chopra; Eduardo Chuquiure; Nadia Giannetti; Stefan Janssens; Jian Zhang; Jose R Gonzalez Juanatey; Sanjay Kaul; Hans-Peter Brunner-La Rocca; Bela Merkely; Stephen J Nicholls; Sergio Perrone; Ileana Pina; Piotr Ponikowski; Naveed Sattar; Michele Senni; Marie-France Seronde; Jindrich Spinar; Iain Squire; Stefano Taddei; Christoph Wanner; Faiez Zannad
Journal:  N Engl J Med       Date:  2020-08-28       Impact factor: 176.079
View more
  2 in total

Review 1.  Mechanisms Underlying Antiarrhythmic Properties of Cardioprotective Agents Impacting Inflammation and Oxidative Stress.

Authors:  Katarina Andelova; Barbara Szeiffova Bacova; Matus Sykora; Peter Hlivak; Miroslav Barancik; Narcis Tribulova
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923

Review 2.  Antiarrhythmic effects and mechanisms of sodium-glucose cotransporter 2 inhibitors: A mini review.

Authors:  Jinchun Wu; Yanmin Liu; Xiaojuan Wei; Xiaofei Zhang; Yi Ye; Wei Li; Xiaoling Su
Journal:  Front Cardiovasc Med       Date:  2022-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.